REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Pfe Ilaclari A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pfizer Pfe Ilaclari Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pfizer Pfe Ilaclari A.S. is the Turkish legal entity of the global biopharmaceutical company Pfizer and operates in the human pharmaceuticals sector. Based in Istanbul, the company is responsible for the registration, importation, marketing, distribution and pharmacovigilance of a wide portfolio of prescription medicines and vaccines across therapeutic areas such as cardiovascular, metabolic diseases, oncology, inflammation and immunology, hospital products and vaccines. It works with healthcare professionals, hospitals, pharmacies and public authorities to make innovative medicines available to patients throughout Turkiye in compliance with local pharmaceutical regulations. Pfizer Pfe Ilaclari A.S. supports clinical research activities and medical education initiatives in cooperation with the global organisation and implements corporate policies on quality, safety and ethics. Strategically, the company focuses on bringing scientifically innovative treatments to the Turkish market, improving patient access through collaboration with the health system, maintaining high standards of compliance and corporate governance and contributing to public health and healthcare system resilience as part of Pfizer's global network.

Headquarters
Levent 199 D:106 No:199 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.

Website: http://www.pfizer.com

Basic Information
Total Employees:
Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.
Financial Auditors:
Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.
Incorporation Date:
December 23, 2014
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Pfizer Pfe Ilaclari A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
65.58%
Total operating revenue
65.58%
Operating profit (EBIT)
166.14%
Net Profit (Loss) for the Period
166.14%
Total Assets
59.14%
Total Equity
53.46%
Operating Profit Margin (ROS)
8.38%
Net Profit Margin
8.38%
Return on Equity (ROE)
19.39%
Debt/Equity
-3.09%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?